Elk Creek Partners’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-2,488,475
| Closed | -$5.33M | – | 166 |
|
|
2017
Q1 | $5.33M | Buy |
2,488,475
+292,420
| +13% | +$626K | 0.33% | 103 |
|
|
2016
Q4 | $9.69M | Buy |
2,196,055
+55,004
| +3% | +$243K | 0.65% | 61 |
|
|
2016
Q3 | $10.4M | Buy |
2,141,051
+626,133
| +41% | +$3.04M | 0.68% | 59 |
|
|
2016
Q2 | $5M | Buy |
1,514,918
+122,172
| +9% | +$403K | 0.36% | 100 |
|
|
2016
Q1 | $4.94M | Buy |
+1,392,746
| New | +$4.94M | 0.37% | 98 |
|